Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|November 3, 2012
Neoplasms of the appendix: current treatment guidelinesSuven Shankar, Panayotis Ledakis, Hatem El Halabi, et al.
Urology|May 28, 2021
Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate Cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyMary Caitlin King, Armando Sardi, Carolina Velez-Mejia, et al.
Clinical Case Reports|December 28, 2020
Germline and somatic genetic alterations in two first-degree relatives with appendiceal low-grade mucinous carcinoma peritoneiMary Caitlin King, Carlos Munoz-Zuluaga, Panayotis Ledakis, et al.
Annals of Surgical Oncology|May 2, 2019
Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPECCarlos Munoz-Zuluaga, Mary Caitlin King, Armando Sardi, et al.
Annals of Surgical Oncology|May 31, 2022
Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPECEkaterina Baron, Armando Sardi, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 17, 2022
Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapyEkaterina Baron, Armando Sardi, Mary Caitlin King, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 22, 2019
Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal originCarlos A Munoz-Zuluaga, Mary Caitlin King, Panayotis Ledakis, et al.
Gynecologic Oncology Reports|March 17, 2025
Association between time to adjuvant chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapySergei Iugai, Armando Sardi, Teresa Diaz-Montes, et al.
Pageof 1